Seeking Alpha

Mylan (MYL -1.4%) says its being sued by Endo Pharmaceuticals (ENDP -1.59%) over its application...

Mylan (MYL -1.4%) says its being sued by Endo Pharmaceuticals (ENDP -1.59%) over its application for approval of frovatriptan succinate EQ, a generic version of Endo's Frova. Both drugs are used to treat acute migraine headaches in adults.
From other sites
Comments (1)
  • crazyhead
    , contributor
    Comment (1) | Send Message
     
    Am I the only one waiting for this generic? I am grateful to Endo for providing me Frova through Patient Assist the last couple years.. but come on, free the generic! At 40 bucks a pill, it's giving me a migraine and it's why I can't afford health insurance:(
    28 Feb 2012, 02:08 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs